FERGUSON WELLMAN CAPITAL MANAGEMENT, INC
Position in JNJ — Johnson & Johnson
CIK 869353
PORTLAND, OR
Position in JNJ
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$114,649,203
+$59,288,216 QoQ
Shares Held
469,028
+75.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.8164544547447.ToString("F0")%
Shared 0.ToString("F0")%
None 4.183545545255294.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FERGUSON WELLMAN CAPITAL MANAGEMENT, INC holds $467,957,783 across 9 Drug Manufacturers - General names. JNJ ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
650,411 | $141,457,887 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
469,028 | $114,649,203 | |
| 3 | AMGN |
Amgen Inc
|
319,238 | $112,323,890 | |
| 4 | MRK |
Merck & Co., Inc.
|
385,956 | $46,426,647 | |
| 5 | NVS |
Novartis AG
|
182,356 | $27,854,879 | |
| 6 | LLY |
ELI LILLY & Co
|
21,116 | $19,421,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
46,278 | $2,806,760 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,327 | $2,136,123 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $114,649,203 | 469,028 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $55,360,987 | 267,509 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $50,096,775 | 270,180 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $41,018,110 | 268,531 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $46,819,451 | 282,317 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $40,439,078 | 279,623 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $47,440,634 | 292,735 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $80,921,630 | 553,651 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $89,963,918 | 568,708 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $88,810,921 | 566,613 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $87,051,167 | 558,916 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $92,869,630 | 561,078 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $86,150,395 | 555,809 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $96,911,956 | 548,610 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $46,065,396 | 281,987 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $51,727,479 | 291,406 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $51,530,154 | 290,753 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $49,801,385 | 291,117 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $47,573,055 | 294,570 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $64,356,175 | 390,653 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $62,940,133 | 382,964 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $61,503,789 | 390,798 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $52,553,300 | 352,991 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $47,752,040 | 339,558 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $44,218,609 | 337,212 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||